Thank you, Mr. Chair.
Thank you to all our witnesses for coming today.
Welcome back, Dr. Falcone. I'm going to start with you.
In your opening remarks, you talked about agility. You said that's one way we can deal with the aftermath of COVID-19. You specifically talked about the integration of research into what I wrote down as “clinical evaluation”. You also said that, if you had time during the questions, you have a number of other ideas you'd like to share.
Here's the platform for you to share those other points of views.